Zymergen Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 507

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Zymergen General Information

Description

Developer of microbe-based diversified inputs and technology intended for agricultural and industrial applications. The company specializes in designing, developing, and manufacturing bio-based breakthrough products that deliver value to customers in a broad range of industries with a combination of biology, chemistry, software, and automation, helping companies to design and create new materials.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 5959 Horton Street
  • Floor 7
  • Emeryville, CA 94608
  • United States
+1 (415)
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Other Materials
Other Commercial Products
Corporate Office
  • 5959 Horton Street
  • Floor 7
  • Emeryville, CA 94608
  • United States
+1 (415)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zymergen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Bankruptcy: Admin/Reorg 03-Oct-2023 Completed Bankruptcy: Admin/Reorg
12. Merger/Acquisition 19-Oct-2022 Completed Generating Revenue
11. IPO 22-Apr-2021 Completed Generating Revenue
10. Later Stage VC (Series D) 29-Jul-2020 Completed Generating Revenue
9. Debt - General 01-Jan-2019 Completed Generating Revenue
8. Later Stage VC (Series C) 13-Dec-2018 Completed Generating Revenue
7. Secondary Transaction - Private 29-Nov-2017 Completed Generating Revenue
6. Early Stage VC (Series B) 29-Nov-2017 Completed Generating Revenue
5. Early Stage VC (Series B) 07-Oct-2016 $130M $174M Completed Generating Revenue
4. Early Stage VC (Series A) 04-Jun-2015 $36.6M $43.6M Completed Generating Revenue
To view Zymergen’s complete valuation and funding history, request access »

Zymergen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B
Series A1 26,158,833 $0.001000 $0.02 $0.25 $0.25 1x $0.25 9.5%
Series A 21,998,250 $0.001000 $0.13 $1.66 $1.66 1x $1.66 7.99%
To view Zymergen’s complete cap table history, request access »

Zymergen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbe-based diversified inputs and technology intended for agricultural and industrial applications. The
Biotechnology
Emeryville, CA
507 As of 2021

Roslin, United Kingdom
 

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zymergen Competitors (5)

One of Zymergen’s 5 competitors is Ingenza, a Venture Capital-Backed company based in Roslin, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ingenza Venture Capital-Backed Roslin, United Kingdom
Arzeda Venture Capital-Backed Seattle, WA
BioTork Venture Capital-Backed Gainesville, FL
Twist Bioscience Formerly VC-backed South San Francisco, CA
Illumina Formerly VC-backed San Diego, CA
You’re viewing 5 of 5 competitors. Get the full list »

Zymergen Patents

Zymergen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024017216-A Polyimide film Pending 27-Jul-2022
JP-2023177577-A Agent containing asymmetric diamine, resin and use of the same Pending 02-Jun-2022
JP-2023083147-A Film and polyimide-based resin Pending 03-Dec-2021
JP-2023083146-A Method for producing polyimide-based resin Pending 03-Dec-2021
US-20250129221-A1 Cadaverine-based polyimides Pending 01-Oct-2021 C08J5/18
To view Zymergen’s complete patent history, request access »

Zymergen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zymergen Acquisitions (3)

Zymergen’s most recent deal was a Merger/Acquisition with Lodo Therapeutics for . The deal was made on 16-May-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lodo Therapeutics 16-May-2021 Merger/Acquisition Discovery Tools (Healthcare)
enEvolv 19-Mar-2020 Merger/Acquisition Biotechnology
Radiant Genomics 08-Jan-2018 Merger/Acquisition Other Commercial Services
To view Zymergen’s complete acquisitions history, request access »

Zymergen ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Zymergen’s complete esg history, request access »

Zymergen FAQs

  • When was Zymergen founded?

    Zymergen was founded in 2013.

  • Where is Zymergen headquartered?

    Zymergen is headquartered in Emeryville, CA.

  • What is the size of Zymergen?

    Zymergen has 507 total employees.

  • What industry is Zymergen in?

    Zymergen’s primary industry is Biotechnology.

  • Is Zymergen a private or public company?

    Zymergen is a Private company.

  • What is Zymergen’s current revenue?

    The current revenue for Zymergen is .

  • How much funding has Zymergen raised over time?

    Zymergen has raised $1.57B.

  • Who are Zymergen’s competitors?

    Ingenza, Arzeda, BioTork, Twist Bioscience, and Illumina are competitors of Zymergen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »